Financhill
Buy
57

EXAS Quote, Financials, Valuation and Earnings

Last price:
$101.55
Seasonality move :
13.8%
Day range:
$101.49 - $101.65
52-week range:
$38.81 - $102.66
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.18x
P/B ratio:
7.69x
Volume:
400.7K
Avg. volume:
8.4M
1-year change:
74.74%
Market cap:
$19.2B
Revenue:
$2.8B
EPS (TTM):
-$5.32

Earnings Data

Next earnings date for EXAS
Feb 25
2026
Most recent earnings per share
-$0.10
Missed by $0.26
(Nov 3/2025)
Consensus Estimate
$0.16
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EXAS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $860.7M -- -- $0.08 --
11/03/2025 Q3 $810.6M $850.7M -$0.10 $0.16 -$0.26
08/06/2025 Q2 $774.7M $811.1M -$0.01 $0.05 -$0.06
05/01/2025 Q1 $688.6M $706.8M -$0.54 -$0.10 -$0.45
02/19/2025 Q4 $701.5M $713.4M -$4.67 -$0.19 -$4.48
11/05/2024 Q3 $717M $708.7M -$0.21 -$0.10 -$0.11
07/31/2024 Q2 $690.1M $699.3M -$0.09 -$0.24 $0.15
05/08/2024 Q1 $626.8M $637.5M -$0.60 -$0.41 -$0.20
02/21/2024 Q4 $639.7M $646.9M -$0.27 -$0.36 $0.08
11/01/2023 Q3 -- $628.3M $0.00 -- --
08/01/2023 Q2 -- $622.1M -$0.45 -- --
05/09/2023 Q1 -- $602.5M -$0.42 -- --
02/21/2023 Q4 -- $553M -$0.72 -- --
11/03/2022 Q3 -- $523.1M -$0.84 -- --
08/02/2022 Q2 -- $521.6M -$0.94 -- --
04/26/2022 Q1 -- $486.6M -$1.04 -- --
02/22/2022 Q4 -- $473.8M -$1.28 -- --
11/02/2021 Q3 -- $456.4M -$0.97 -- --
07/28/2021 Q2 -- $434.8M -$1.03 -- --
05/04/2021 Q1 -- $402.1M -$0.18 -- --
02/16/2021 Q4 -- $466.3M -$2.67 -- --
10/29/2020 Q3 -- $408.4M -$1.35 -- --
07/30/2020 Q2 -- $268.9M -$0.45 -- --
05/06/2020 Q1 -- $347.8M -$0.91 -- --
02/11/2020 Q4 -- $295.6M $0.54 -- --
10/29/2019 Q3 -- $218.8M -$0.31 -- --
07/30/2019 Q2 -- $199.9M -$0.30 -- --
04/30/2019 Q1 -- $162M -$0.66 -- --
02/21/2019 Q4 -- $143M -$0.44 -- --
10/30/2018 Q3 -- $118.3M -$0.37 -- --
08/01/2018 Q2 -- $102.9M -$0.30 -- --
04/26/2018 Q1 -- $90.3M -$0.33 -- --
02/22/2018 Q4 -- $87.4M -$0.18 -- --
10/31/2017 Q3 -- $72.6M -$0.23 -- --
07/25/2017 Q2 -- $57.6M -$0.27 -- --
04/27/2017 Q1 -- $48.4M -$0.32 -- --
02/21/2017 Q4 -- $35.2M -$0.34 -- --
10/26/2016 Q3 -- $28.1M -$0.36 -- --
07/26/2016 Q2 -- $21.2M -$0.46 -- --
05/03/2016 Q1 -- $14.8M -$0.49 -- --
02/24/2016 Q4 -- $14.4M -$0.41 -- --

EXACT Sciences Corp. Earnings Questions

  • How Much did EXACT Sciences Corp. Generate in Revenue Last Quarter?

    EXACT Sciences Corp. reported $850.7M worth of top line sales in its most recent quarter.

  • Did EXACT Sciences Corp. Beat Earnings Last Quarter?

    EXACT Sciences Corp. announced earnings per share of -$0.10 which represents a miss of analyst forecast a $0.16 per share.

  • Is EXACT Sciences Corp. Profitable?

    EXACT Sciences Corp. reported $583.9M that represents $3.09 per share over the last quarter.

  • What is the Analyst Consensus for EXACT Sciences Corp. EPS Next Year?

    EXACT Sciences Corp.'s earnings are forecast to decrease from -$5.59 per share to -$0.57 per share next year representing a decrease of -99.99%.

  • When is EXACT Sciences Corp.'s Earnings Date?

    EXACT Sciences Corp.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock